Drug Approval

FDA FDA Regulations Clinical Trials Regulatory Affairs Regulatory Processes Regulatory Bodies Generic Drugs Health Canada Regulatory Review Regulations Regulatory Agencies FDA Approval Process FDA Advisory Committee USFDA U.S. Food and Drug Administration Alzheimer's Disease

4 ARTICLES

4w ago

Eli Lilly Licenses AlzeCure’s Preclinical Alzheimer’s Candidate

The deal gives Lilly global development rights to ACD680 with a $10 million upfront payment and milestone and royalty terms that could push pre-royalty payouts past $1 billion pending Swedish foreign investment approval.

6 ARTICLES

5mo ago

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

4 ARTICLES

8mo ago

FDA Approves J&J’s Caplyta for Major Depressive Disorder